|
Cerus Corporation (CERS) DCF Valoración
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Cerus Corporation (CERS) Bundle
Ingementada para su precisión, nuestra calculadora DCF (CERS) le permite evaluar la valoración de Cerus Corporation utilizando datos financieros actualizados, al tiempo que ofrece una flexibilidad completa para modificar todos los parámetros clave para mejorar las proyecciones.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 74.6 | 91.9 | 130.9 | 162.0 | 156.4 | 189.9 | 230.7 | 280.2 | 340.3 | 413.3 |
| Revenue Growth, % | 0 | 23.14 | 42.36 | 23.83 | -3.51 | 21.46 | 21.46 | 21.46 | 21.46 | 21.46 |
| EBITDA | -64.6 | -51.4 | -46.0 | -34.1 | -26.5 | -81.9 | -99.5 | -120.8 | -146.7 | -178.2 |
| EBITDA, % | -86.56 | -55.89 | -35.14 | -21.03 | -16.97 | -43.12 | -43.12 | -43.12 | -43.12 | -43.12 |
| Depreciation | 2.4 | 4.5 | 4.6 | 4.6 | 2.6 | 6.1 | 7.4 | 9.0 | 10.9 | 13.3 |
| Depreciation, % | 3.22 | 4.85 | 3.49 | 2.81 | 1.66 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 |
| EBIT | -67.0 | -55.8 | -50.6 | -38.6 | -29.1 | -88.0 | -106.9 | -129.8 | -157.6 | -191.5 |
| EBIT, % | -89.77 | -60.73 | -38.63 | -23.84 | -18.63 | -46.32 | -46.32 | -46.32 | -46.32 | -46.32 |
| Total Cash | 85.7 | 133.6 | 129.4 | 102.2 | 65.9 | 153.5 | 186.4 | 226.4 | 274.9 | 333.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 16.9 | 21.2 | 25.1 | 34.4 | 35.5 | 41.3 | 50.2 | 61.0 | 74.0 | 89.9 |
| Account Receivables, % | 22.62 | 23.03 | 19.2 | 21.24 | 22.7 | 21.76 | 21.76 | 21.76 | 21.76 | 21.76 |
| Inventories | 19.5 | 23.3 | 26.8 | 29.0 | 39.9 | 43.8 | 53.2 | 64.6 | 78.5 | 95.3 |
| Inventories, % | 26.11 | 25.3 | 20.47 | 17.9 | 25.5 | 23.06 | 23.06 | 23.06 | 23.06 | 23.06 |
| Accounts Payable | 22.2 | 24.2 | 35.6 | 33.0 | 23.8 | 45.2 | 54.8 | 66.6 | 80.9 | 98.3 |
| Accounts Payable, % | 29.72 | 26.34 | 27.21 | 20.37 | 15.25 | 23.78 | 23.78 | 23.78 | 23.78 | 23.78 |
| Capital Expenditure | -8.9 | -1.6 | -.9 | -2.0 | -4.6 | -7.1 | -8.6 | -10.4 | -12.7 | -15.4 |
| Capital Expenditure, % | -11.97 | -1.76 | -0.6954 | -1.23 | -2.94 | -3.72 | -3.72 | -3.72 | -3.72 | -3.72 |
| Tax Rate, % | -0.44746 | -0.44746 | -0.44746 | -0.44746 | -0.44746 | -0.44746 | -0.44746 | -0.44746 | -0.44746 | -0.44746 |
| EBITAT | -67.3 | -56.1 | -50.9 | -39.1 | -29.3 | -88.0 | -106.9 | -129.8 | -157.6 | -191.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -88.0 | -59.3 | -43.3 | -50.6 | -52.4 | -77.4 | -116.6 | -141.6 | -172.0 | -208.9 |
| WACC, % | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -524.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -213 | |||||||||
| Terminal Value | -2,745 | |||||||||
| Present Terminal Value | -1,723 | |||||||||
| Enterprise Value | -2,247 | |||||||||
| Net Debt | 84 | |||||||||
| Equity Value | -2,331 | |||||||||
| Diluted Shares Outstanding, MM | 180 | |||||||||
| Equity Value Per Share | -12.93 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real CERS financials.
- Real-World Data: Historical data and forward-looking estimates (as highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effects of your inputs on Cerus Corporation’s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive Financial Data: Cerus Corporation’s (CERS) historical financial statements and pre-filled projections.
- Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
- Real-Time Valuation: Instantly view Cerus Corporation’s (CERS) intrinsic value updates as you modify inputs.
- Intuitive Visualizations: Dynamic dashboard charts illustrate valuation outcomes and essential metrics.
- Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the prebuilt Excel template featuring Cerus Corporation's (CERS) data.
- Step 2: Navigate through the pre-filled sheets to grasp the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view the updated results, including Cerus Corporation's (CERS) intrinsic value.
- Step 5: Make well-informed investment decisions or create reports based on the outputs.
Why Choose This Calculator for Cerus Corporation (CERS)?
- Accurate Data: Up-to-date Cerus Corporation financials provide dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Ready-to-use calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Streamlined design and clear instructions make it accessible for all users.
Who Should Use This Product?
- Healthcare Professionals: Understand the latest advancements in medical technologies and their market implications.
- Researchers: Utilize data on Cerus Corporation (CERS) for academic studies and clinical research.
- Investors: Evaluate your investment strategies by analyzing the performance and growth potential of Cerus Corporation (CERS).
- Market Analysts: Enhance your analysis with comprehensive data and insights on Cerus Corporation (CERS).
- Biotech Entrepreneurs: Learn from the operational strategies of established companies like Cerus Corporation (CERS).
What the Template Contains
- Pre-Filled Data: Includes Cerus Corporation’s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Cerus Corporation’s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.